Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947665312> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2947665312 abstract "Clinical pharmacology studies are one of the major types of regulatory data submitted for review of therapeutic proteins regulated by the Center for Biologics Evaluation and Research (CBER).The primary objective of the current study is to provide an overview of the role of clinical pharmacology including pharmacokinetics (PK), pharmacodynamics (PD) and exposure-response analysis at CBER. Furthermore, we aim to provide a baseline estimate for the use of quantitative clinical pharmacology studies prior to implementation of FDA's model-informed drug development (MIDD) pilot programme.We survey original Biologics License Applications (BLAs) for plasma-derived and related recombinant therapeutic protein products approved by CBER/FDA (2008-2017).There were 37 original BLAs that met our inclusion criteria, and 34 of these products (92%) contained human PK data as part of the biological licensing. The products were broadly classified as coagulation factors (54%), IgG and related proteins (24%), and other therapeutic proteins (22%). Coagulation factor VIII and IX products constitute 32% of the BLAs and indicated for treatment of haemophilia A and B, respectively. Twelve products (35%) used model-based approaches (population PK/PD and exposure-response). Over the past 5 years (2013 to 2017), there is a trend for increased application of MIDD approaches as compared to the previous cohort years (2008 to 2012).In conclusion, clinical pharmacology has played a major role in regulatory review of plasma-derived products, and we expect that the application of quantitative methods will further evolve for these products under the FDA MIDD programme." @default.
- W2947665312 created "2019-06-07" @default.
- W2947665312 creator A5014032609 @default.
- W2947665312 creator A5037939650 @default.
- W2947665312 creator A5087332112 @default.
- W2947665312 date "2019-05-26" @default.
- W2947665312 modified "2023-10-16" @default.
- W2947665312 title "Clinical Pharmacology Review of Plasma‐derived and Recombinant Protein Products: CBER Experience and Perspectives on Model‐Informed Drug Development" @default.
- W2947665312 cites W1973292712 @default.
- W2947665312 cites W1986601719 @default.
- W2947665312 cites W2023806093 @default.
- W2947665312 cites W2038900628 @default.
- W2947665312 cites W2045886098 @default.
- W2947665312 cites W2065463493 @default.
- W2947665312 cites W2079937572 @default.
- W2947665312 cites W2093123260 @default.
- W2947665312 cites W2122398779 @default.
- W2947665312 cites W2143548516 @default.
- W2947665312 cites W2550413464 @default.
- W2947665312 cites W2601491278 @default.
- W2947665312 cites W2619778077 @default.
- W2947665312 cites W2761634319 @default.
- W2947665312 cites W2806180107 @default.
- W2947665312 cites W2910121838 @default.
- W2947665312 doi "https://doi.org/10.1111/hae.13767" @default.
- W2947665312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31131515" @default.
- W2947665312 hasPublicationYear "2019" @default.
- W2947665312 type Work @default.
- W2947665312 sameAs 2947665312 @default.
- W2947665312 citedByCount "6" @default.
- W2947665312 countsByYear W29476653122019 @default.
- W2947665312 countsByYear W29476653122020 @default.
- W2947665312 countsByYear W29476653122021 @default.
- W2947665312 countsByYear W29476653122022 @default.
- W2947665312 crossrefType "journal-article" @default.
- W2947665312 hasAuthorship W2947665312A5014032609 @default.
- W2947665312 hasAuthorship W2947665312A5037939650 @default.
- W2947665312 hasAuthorship W2947665312A5087332112 @default.
- W2947665312 hasConcept C111113717 @default.
- W2947665312 hasConcept C112705442 @default.
- W2947665312 hasConcept C126322002 @default.
- W2947665312 hasConcept C187212893 @default.
- W2947665312 hasConcept C2778385053 @default.
- W2947665312 hasConcept C2780035454 @default.
- W2947665312 hasConcept C42404028 @default.
- W2947665312 hasConcept C535046627 @default.
- W2947665312 hasConcept C63433958 @default.
- W2947665312 hasConcept C64903051 @default.
- W2947665312 hasConcept C71924100 @default.
- W2947665312 hasConcept C98274493 @default.
- W2947665312 hasConceptScore W2947665312C111113717 @default.
- W2947665312 hasConceptScore W2947665312C112705442 @default.
- W2947665312 hasConceptScore W2947665312C126322002 @default.
- W2947665312 hasConceptScore W2947665312C187212893 @default.
- W2947665312 hasConceptScore W2947665312C2778385053 @default.
- W2947665312 hasConceptScore W2947665312C2780035454 @default.
- W2947665312 hasConceptScore W2947665312C42404028 @default.
- W2947665312 hasConceptScore W2947665312C535046627 @default.
- W2947665312 hasConceptScore W2947665312C63433958 @default.
- W2947665312 hasConceptScore W2947665312C64903051 @default.
- W2947665312 hasConceptScore W2947665312C71924100 @default.
- W2947665312 hasConceptScore W2947665312C98274493 @default.
- W2947665312 hasIssue "4" @default.
- W2947665312 hasLocation W29476653121 @default.
- W2947665312 hasLocation W29476653122 @default.
- W2947665312 hasOpenAccess W2947665312 @default.
- W2947665312 hasPrimaryLocation W29476653121 @default.
- W2947665312 hasRelatedWork W1603416295 @default.
- W2947665312 hasRelatedWork W1978032370 @default.
- W2947665312 hasRelatedWork W1979757582 @default.
- W2947665312 hasRelatedWork W2080081537 @default.
- W2947665312 hasRelatedWork W2329258414 @default.
- W2947665312 hasRelatedWork W2332367370 @default.
- W2947665312 hasRelatedWork W2399977644 @default.
- W2947665312 hasRelatedWork W2400461952 @default.
- W2947665312 hasRelatedWork W3089081291 @default.
- W2947665312 hasRelatedWork W79555446 @default.
- W2947665312 hasVolume "25" @default.
- W2947665312 isParatext "false" @default.
- W2947665312 isRetracted "false" @default.
- W2947665312 magId "2947665312" @default.
- W2947665312 workType "article" @default.